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Tuberculosis remained a very significant cause of death in Ireland until the mid-20th century and still
occupies a prominent position in the folk memory. As I show with reference to recent Irish media
coverage, the global resurgence of tuberculosis is therefore viewed with concern in Ireland. Using data
collated by the Health Protection Surveillance Centre between 1998 and 2005 however, I show that the
recent increase in tuberculosis incidence in Ireland is less than is popularly perceived. This increase is
largely associated with economic immigrants attracted to Ireland by the ‘Celtic Tiger’ economic boom,
but there is little evidence to suggest that this has had a negative impact on the Irish-born population.
Drug resistance is still a small but growing problem. Whilst vigilance is required, it is argued that the
recent increase does not at present indicate a likely return to the situation in the mid-20th century.
 2008 Elsevier Ltd. All rights reserved.Introduction
Tuberculosis is an ancient disease. Its exact origins are
unknown, but it seems likely that humans were infected when they
started living in close proximity to cattle during the agricultural
revolution in the Neolithic (Karlen, 2000). But whatever its origins,
tuberculosis (also known as consumption or phthisis) remained
one of the leading causes of death throughout most of history.
Although mortality rates began to decline in developed countries in
the 19th century, they still remained significant well into the 20th
century, but the introduction of effective drugs, such as strepto-
mycin in 1944, isoniazid in 1952 and rifampicin in the 1970s, raised
hopes that tuberculosis could eventually be defeated. Its global
resurgence in the early 1980s, due to a myriad of factors, was
consequently a source of dismay and concern, resulting in it being
declared a global health emergency by the WHO in 1993.
This resurgence is thought to be connected with the emergence
of HIV infection. Infection by the causal agent (Mycobacterium
tuberculosis) does not necessarily result in active tuberculosis. In
a majority of cases the infected cells are surrounded by macro-
phages, B and T lymphocytes and fibroblasts to form a granuloma
which in effect seals in the infection (Playfair, 2004). The immune
system is thereby able to contain the infection and stop it from
spreading, either within the infected person or to other people.
Many infected people carry latent tuberculosis for the remainder of
their lives without any obvious symptoms. However, if their
immune system becomes compromised, for example by drugAll rights reserved.abuse, dietary deficiencies, old age or HIV infection, then the
immune system may no longer be able to contain the infection
which may then become active. Left untreated, active tuberculosis
is frequently fatal. It may also be transmitted to others, resulting in
new infections. HIV infection therefore has serious implications not
only for those already carrying a latent infection, but also for other
people not already infected by tuberculosis.
Drug resistance has also contributed to the global resurgence. As
low-cost drugs have become less effective, tuberculosis may be left
untreated in developing countries where the cost of effective
treatments remains prohibitive. This, in turn, results in further new
infections (Desowitz, 2002). In some instances apparent prevalence
rates may have increased due to better surveillance, but in other
cases the real prevalence rates may have increased due to a dete-
rioration in the public health systems (Garrett, 2001).
There are indications that the most recent pandemic may have
peaked around 2005, but the absolute number of people with
tuberculosis is larger now than at any point in history. An estimated
2 billion people (or one person in three worldwide) carry the
bacillus, resulting in 8.8 million new cases of active tuberculosis
and 1.6 million deaths in 2005 (World Health Organization, 2007).
Although Ireland has largely escaped the worst of the new wave
of tuberculosis, its resurgence elsewhere is a source of concern.
Tuberculosis occupies a prominent position within the Irish psyche
because it remained a major cause of death in Ireland much later
than elsewhere. Ireland actually had lower tuberculosis mortality
rates than Britain in the mid-19th century (despite the horrendous
living conditions generated in Ireland by the Great Famine in the
1840s), but tuberculosis mortality rates increased in Ireland
throughout the second half of the 19th century at a time when they
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enced considerably higher tuberculosis mortality than either
England or Scotland (Countess of Aberdeen, 1908). There was some
reduction in mortality in the first half of the 20th century, but the
disparity between Ireland and Britain continued to widen due to
the much more rapid improvement in Britain. For example, the
crude death rate in Ireland in 1922 was 153 per 100,000, compared
with 112 in England and Wales (Jones, 2001). Tuberculosis
remained one of the major causes of death in Ireland as late as the
1940s, with the annual crude rate varying between 125 and 147 per
100,000 between 1940 and 1945 (Deeny, 1954). However, the
introduction of streptomycin and other antibiotics brought about
a major transformation in the 1950s. Whilst incidence and
mortality rates subsequently declined to a small fraction of what
they had been previously, the trauma associated with tuberculosis
still remains fresh in the memory of many of its older citizens. The
global resurgence in tuberculosis is consequently topical and
receives significant media coverage. For example, the Irish Times
published 59 articles in 2007 which contained a reference to
tuberculosis. Some of these were only passing mentions in articles
on historical figures who had developed tuberculosis at some stage
in their lives, but a majority reported on contemporary issues
affecting either less developed countries or Ireland.
Four themes may be detected in the media coverage:
1. Tuberculosis rates are now increasing in Ireland after a lengthy
decline, with an implicit threat that we could see a return to the
‘bad old days’.
When compared with 2001 figures, there was a 7.1pc increase in
the TB notifications in 2002. (Anonymous, 2004a)
This is a disease that many thought had been banished forever from
Ireland . Tuberculosis wreaked havoc with the lives of thousands
of Irish people for generations until tackled seriously by the Health
Plan of the late Dr Noel Browne, as Heath Minister in the 1950s.
(Anonymous, 2001)
Whether it’s lung cancer, asthma, chronic obstructive pulmonary
disease, tuberculosis or cystic fibrosis – the picture is the same;
death rates and prevalence are either rising or higher than they
should be and the resources to effectively prevent, diagnose and
treat these diseases are inadequate. (Houston, 2008)
2. The recent increase in Ireland is associated with new immigrants.
A World Health organisation survey of more than 67,000 TB
patients in 77 countries, published in Brussels, identifies three new
member states – Latvia, Lithuania and Estonia – as among those in
eastern Europe and Central Asia where multi drug-resistant TB,
known as MDR-TB, is rampant. (Anonymous, 2004b)
Although Africa has only 11 per cent of the world’s population, it
accounts for more than a quarter of the nine million active TB cases
and two million deaths caused every year by the disease. It is also
the only continent where infection rates are increasing every year.
(Anonymous, 2005)
3. The upsurge in tuberculosis is fuelled by HIV infection.
You are 200 times more likely to develop TB if you have HIV than if
you didn’t, and multi-drug resistant TB is linked to people with HIV
who are more difficult to treat because they have drug intolerance.
(Dempsey, 2003)
4. Tuberculosis is becoming more difficult to treat due to drug
resistance.
‘‘A new form of tuberculosis, resistant to most current drug ther-
apies and described by the World Health Organisation as ‘virtuallyincurable’ in developing countries, has been detected in Irish
patients. . Ireland has between five and 10 cases (of MDR-TB)
a year. We know that will increase. It’s inevitable.’’ (Ahlstrom &
O’Sullivan, 1997)
This paper assesses the extent to which the concerns propa-
gated by the media with regard to each of these themes accurately
reflect the situation in Ireland.
Data sources
Tuberculosis is a notifiable disease in Ireland under the Infec-
tious Disease Regulations 1981 (and subsequent amendments).
Only symptomatic cases are reported (National Disease Surveil-
lance Centre, 2003), but in theory every clinically and/or radio-
logically diagnosed case displaying symptoms should be reported
to a Medical Officer of Health (usually the Director of Public Health
for the local area). This information is collated by the Health
Protection Surveillance Centre (HPSC) – formerly the National
Disease Surveillance Centre (NDSC) – which publishes summary
statistics in an annual Report on the Epidemiology of Tuberculosis in
Ireland (available on-line at http://www.ndsc.ie/hpsc). This
provides a statistical breakdown on a number of features in addi-
tion to incidence and mortality rates. The first report, for 1998, was
published in 2000, but it included figures calculated retrospectively
back to 1991. The most recent report provides information for 2005.
Mortality figures are also available from the Report on Vital Statis-
tics, published annually by the Central Statistics Office (CSO) (and
available on-line at http://www.cso.ie). The HPSC uses a conserva-
tive EU-based clinical definition of tuberculosis, whereas the CSO
estimates of mortality from tuberculosis are based on death certi-
fication and are normally slightly higher than the estimates
reported by the HPSC. However, they follow the same trends as the
HPSC reported mortality figures. This paper focuses on the data
provided by the HPSC.
65.7% of the cases reported during the period 1998–2005 were
pulmonary, 25.2% were extrapulmonary, and 7.6% were both
pulmonary and extrapulmonary. These percentages remained fairly
stable throughout the study period. 65.9% of the pulmonary cases
were confirmed either by isolation of M. tuberculosis complex
(except Mycobacterium bovis BCG) from any clinical specimen
whilst 43.7% were laboratory confirmed by microscopic identifi-
cation of acid-fast bacilli in spontaneous or induced sputum. 69.6%
of all cases were confirmed by one method or both, whilst the
unconfirmed cases were fairly evenly divided between those
testing negatively (15.6%) and those where testing was not done or
the outcome was not reported (14.8%). The percentage testing
positively increased during the study period from a low of 61.0% in
1998 to a high of 72.6% in 2004, with the biggest change occurring
between 2001 and 2003.
This study reports the figures for all notified cases, whether
pulmonary or extrapulmonary and whether confirmed or
otherwise.
Incidence rates
The number of tuberculosis notifications and the crude inci-
dence rates for 1991–2005 are graphed in Fig. 1. The general pattern
in both graphs is, not surprisingly, similar. There was a decline
throughout the 1990s, except for a ‘spike’ in 1998 and 1999. It is not
clear whether this indicates an actual increase in incidence in these
years or whether it may simply reflect a change in the notification
procedures associated with the early publication of the annual
reports. The downward trend resumed in 2000 before bottoming
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Fig. 1. Pulmonary and extrapulmonary tuberculosis notifications and incidence rates, 1991–2005.
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increase in incidence is less marked than the increase in the
number of cases, suggesting that the increase in cases may simply
reflect a very rapid increase in population. Also, whilst these recent
trends are in the ‘wrong’ direction, the absolute number of cases
and incidence rates (per 100,000) remain low, both historically and
in comparison with other European countries (World Health
Organization, 2008). The increases may even be artifactual and
simply reflect improvements in the notification and surveillance
procedures. Also, even if the increases are accepted as genuine, it
should be noted that the incidence rate in 2005 was less than those
in the mid-1990s, when tuberculosis was still generally considered
to have been defeated. Thus, whilst we may have the beginnings of
a problem, it would appear premature to describe it as a crisis.
The New Irish
Ireland’s demographic history over the past two centuries was
predominantly one of out-migration and population decline. Mass
emigration was triggered by the Famine in the 1840s, but continued
at a lower although still substantial rate throughout most of the
20th century, producing a net population decline that persisted
until the 1960s, despite a net natural increase (i.e. an excess of
births over deaths) throughout most of this period. This downward
trend in total population was eventually reversed around 1962.
However, although total population has persistently increased
since the early 1960s, out-migration continued to exceed in-
migration until the mid-1990s, apart from a brief interlude in the
late 1970s when there was a short period of net in-migration
(mainly comprised of returned emigrants). As a result, Ireland, in
contrast to most west European countries, had a very small
immigrant population as late as the mid-1990s. The overwhelming
majority of people living in Ireland at that time were either Irish-
born or of Irish descent.
This situation has changed dramatically since 1996 due to
large-scale in-migration associated with an economic boom (the
so-called ‘Celtic Tiger’). Some of the new immigrants were returned
emigrants, taking advantage of the improved economic situation to
return home, but many of them had no previous Irish connections.
The percentage of people born outside Ireland or the UK (many of
whom are Irish nationals) increased from 1.7% in 1996 to 8.2% in
2006 (Central Statistics Office, 2007).
Relations between the Irish-born and the foreign-born remain
quite good – at least as perceived from the perspective of the Irish-
born. Whilst language differences provide a barrier to integration,there is little evidence so far of overt racial or ethnic tensions. The
new immigrants are predominantly young, and (especially the East
Europeans) are generally perceived as hard-working, industrious
and polite. However, the extent and unprecedented nature of these
changes is creating a rapidly changing context with new anxieties,
so there may be a degree of latent xenophobia. The idea that
tuberculosis could be reintroduced into Ireland by foreigners could
therefore feed certain unarticulated prejudices.
The HPSC reports provide figures on place of birth of tubercu-
losis patients. These indicate that the burden of tuberculosis falls
more heavily on the foreign-born population – i.e. there is a higher
incidence amongst the foreign-born (24.8 per 100,000 as compared
with 8.3 per 100,000 for the Irish-born in 2005). This may reflect
poorer living conditions amongst the foreign-born within Ireland,
but given the extent of the differences in incidence rates between
different immigrant groups (which are not reflected by corre-
sponding differences in living conditions), it is more likely to
indicate that they are already infected when they arrive.
The expectation of many Irish is that tuberculosis incidence
amongst immigrants would be highest amongst Africans due to
HIV. However, the incidence is almost as high for Asians. Africans
account for 32.3% of the non Irish-born tuberculosis cases, but
represent only 7.0% of the immigrant population; Asians account
for 39.4% of non Irish-born tuberculosis cases, but represent only
9.1% of immigrant population. There are major variations within
each group. Nigerians are the largest tuberculosis group amongst
the African-born, but they are also the largest African immigrant
group, so their incidence rate is not exceptionally high by African
standards. Indians and Pakistanis are the largest TB groups amongst
the Asian-born, whereas other Asian groups (e.g. the Chinese) have
much lower rates. Within the European immigrants, tuberculosis
rates are high for Romanians, but low for Poland and the Baltic
states who comprise a much larger percentage of the total immi-
grant population.
The total number of notifications for Irish- and foreign-born
persons each year from 1998 to 2005 is graphed in Fig. 2. The
absolute number and percentage of cases amongst the foreign-born
have generally increased but, although the total number of cases
has increased since 2001, it is noticeable that the absolute number
of cases amongst the Irish-born has generally continued to decline.
In other words, the increase in the total number of notifications is
solely attributable to the increase in cases amongst foreign-born
residents. This, in turn, may simply reflect the rapidly increasing
size of the foreign-born population. While this would suggest that





























Foreign Born Irish Born
Fig. 2. Place of birth of all notified cases of pulmonary and extrapulmonary tubercu-
losis, 1998–2005.
D. Pringle / Social Science & Medicine 68 (2009) 620–624 623immigrant populations, it also suggests that this is not resulting in
a significant number of infections amongst the Irish-born arising
from contacts with the new immigrants.
This conclusion receives support if one considers the age
profiles of the Irish- and foreign-born cases. Fig. 3 shows the age
breakdown for 2004. The age profiles are clearly quite different. The
median age for foreign-born patients in 2004 was 29.6, whereas for
the Irish-born patients it was 50.3. This suggests that many of the
Irish-born patients are elderly people who may have had latent TB
for decades, rather than being recently infected by new immigrants.
There was an increase in the age specific incidence rates for
people aged 15–24, 25–34 and 35–44 between 1998 and 2005, but
a decline for all other age groups. The increases in these three age
groups would again appear to suggest that they are associated with
immigrant populations, whereas the decline in the other age
groups would suggest that the incidence of tuberculosis is
continuing to decline in the Irish-born population, even in the most
susceptible age groups.
Overall, the evidence would suggest that the recent increase in
tuberculosis incidence is associated with immigrant populations,

































Fig. 3. Age distribution of Irish- and foreign-born pulmonary and extrapulmonary
tuberculosis cases, 2004.HIV infection
The cumulative number of known HIV infections in Ireland up to
the end of June 2007 was 4623, resulting in 941 cases of AIDS, of
which 402 had died (Health Protection Surveillance Centre, 2007).
The number of new AIDS cases (reflecting earlier infections) peaked
in the early- to mid-1990s, but there was a fourfold increase in new
HIV infections between 1998 and 2003, resulting in a renewed
upsurge in AIDS cases. The number of new HIV infections and AIDS
diagnoses would now appear to be declining since 2003/2004. This
‘second epidemic’ is largely associated with new immigrants. For
example, 42% of new HIV cases in the first two quarters of 2007 for
whom information on ‘geographic origin’ is available were from
Sub-Saharan Africa, whilst a further 18% were from other countries.
The upsurge in HIV infections between 1998 and 2003 was paral-
leled by a similar upsurge in infections through heterosexual
contacts, whereas new cases arising from intravenous drug use or
male–male sexual contacts (pathways associated more with the
Irish-born) increased only slightly.
The implications of HIV infection for tuberculosis within Ireland
are unclear. Only 24 of the 882 new cases in 2004 and 2005 were
reported to be infected by HIV, but no information was available on
830 of these cases. However, there are grounds for suspecting that
HIV infection within Ireland may not be a major factor for the
increasing number of tuberculosis cases. HIV may be a significant
factor for those from Sub-Saharan Africa who were already carrying
the tubercle bacillus when they arrived in Ireland, but HIV rates in
Ireland are low for persons from other countries that provide the
largest numbers of foreign-born tuberculosis cases. Also, within
Ireland there is a mismatch in the regional patterns of tuberculosis
and HIV: HIV incidence is much higher in the east, whereas
tuberculosis incidence tends to be as high or higher in the south
and west. One must always be wary of the ecological fallacy, but
there is little to suggest that HIV infection is a major factor in the
incidence of tuberculosis in Ireland.Drug resistance
The fourth concern articulated by the media is that tuberculosis
may be becoming less amenable to treatment as M. tuberculosis
develops resistance to the drugs used to treat it. Several levels of
resistance may be identified. Resistance to the two main drugs used
in the treatment of tuberculosis (isoniazid and rifampicin) is
referred to as multiple drug resistance (MDR-TB); resistance to
isoniazid and rifampicin, plus resistance to a quinolone and at least
one other second line drug is referred to as extensively drug
resistance (XDR-TB). The fear in Ireland, as elsewhere, is that TB
could become untreatable. Indeed, the first case of complete drug
resistance (CDR-TB), in which the patient failed to respond to every
known drug, was reported in Italy in early 2007 (McKenzie, 2007).
Data provided by HPSC suggests that the problem remains small
in Ireland in comparison with other countries, although it will
almost certainly become a more serious problem in the future. Only
4.6% of the isolates tested over the period 1998–2005 showed
resistance to any drugs. In most cases they showed resistance to
only one drug. In fact, over this period there was a total of only 12
cases of MDR-TB and one case of XDR-TB. Of the isolates showing
drug resistance, 79% showed resistance to isoniazid, 17% to rifam-
picin, 26% to streptomycin, 11% to pyrazinamide and 8% to
ethambutol.
Despite this generally positive situation, there are a couple of
disturbing trends. First, although there has not been a noticeable
increase in MDR-TB, there has been an increase in resistance to
a single drug (especially isoniazid). The second is that a dispropor-
tionate percentage of resistant strains (57%) were isolated from
D. Pringle / Social Science & Medicine 68 (2009) 620–624624foreign-born patients, suggesting that drug resistance may be being
imported from elsewhere.
Discussion
Curtis (2004), in a review of several studies of tuberculosis in
Britain and the US in the 1990s, notes that prevalence rates were
generally higher amongst ethnic minorities, but that there was
little evidence to suggest these rates were transmitted to the
majority populations. This finding is supported by the recent
experience in Ireland. However, the studies reported by Curtis also
suggest that the higher prevalence amongst ethnic minorities was
primarily a function of their poorer living conditions (i.e. crowding,
poverty) rather than migration. This needs to be explored in more
detail, but the indications in Ireland are that tuberculosis is being
‘imported’ (e.g. prevalence rates in Ireland are higher for immigrant
groups from high prevalence countries than for immigrant groups
from low prevalence countries living in similar social conditions).
Thomas McKeown argued that the decline in mortality from
tuberculosis in England and Wales could be traced back to the
1840s (and possibly even earlier) (McKeown, 1976, 1979, 1988).
Although the introduction of streptomycin in the 1940s brought
about a significant acceleration in the rate of decline, most of the
improvement with regard to reduced mortality in England and
Wales had already occurred long before the introduction of anti-
biotics. Similar tends in most other infectious diseases led
McKeown to argue that medical interventions played a relatively
insignificant role in the epidemiological transition from high
mortality caused by infectious diseases to lower mortality later in
life primarily associated with non-infectious diseases. This transi-
tion, he argued, owed more to people developing more effective
immune systems due to an improved diet and better living condi-
tions. Several critics, most notably Szreter (1988), argued that
McKeown overstated the importance of economic progress and
underestimated the impact of public health reforms, but there is
a widespread acceptance of his argument that advances in thera-
peutic medicine arrived too late to explain the reduction in
mortality from infectious diseases and a corresponding increase in
life expectancy.
The situation in Ireland with regards to tuberculosis appears to
be somewhat different. Tuberculosis remained a very significant
cause of death in Ireland into the 1950s. This is probably because
living conditions failed to improve in Ireland at the same rate as
they did in Britain. Indeed, this failure is one of the major reasons
for the predominance of net out-migration in Ireland through to the
mid-1990s. The decline of tuberculosis in Ireland was therefore
much later than in Britain and owed more to direct medical
interventions.
However, the socio-economic context has changed. The
economy has been steadily improving since the 1960s and the past
decade saw a dramatic increase in living standards as a result of the
Celtic Tiger and a reversal of migration flows resulting in very heavy
in-migration. Thus, if McKeown’s ideas are correct (or even those of
his critics), it is very unlikely that tuberculosis could ever pose the
threat that it once did following the country’s recent rapid increase
in prosperity.
Although tuberculosis occupies a special place in the Irish
psyche because of its relatively recent history, the evidence would
suggest that it should not be a major source of concern. However, itis important to avoid complacency and to remain vigilant. We may
be witnessing the beginnings of a more serious situation, associated
with sections of the new immigrant population. Given the prom-
inent position that tuberculosis occupies within the Irish folk
memory, there is a risk that the fears generated by resurgent
tuberculosis could translate into more overt forms of xenophobia
(despite the lack of evidence to suggest that the Irish-born are
adversely affected). It is therefore essential to ensure access to
effective treatment for all members of the population, especially
the new immigrants, if we are to continue to minimise the threat
posed by drug resistance. Failure to do so could generate a xeno-
phobic reaction which would drive the problem underground and
make it much more difficult to contain.Acknowledgments
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